Guggenheim Capital’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-61,197
| Closed | -$1.91M | – | 1655 |
|
|
2025
Q1 | $1.91M | Sell |
61,197
-11,884
| -16% | -$370K | 0.02% | 652 |
|
|
2024
Q4 | $1.86M | Sell |
73,081
-82,768
| -53% | -$2.11M | 0.02% | 674 |
|
|
2024
Q3 | $4.41M | Buy |
155,849
+4,864
| +3% | +$138K | 0.03% | 570 |
|
|
2024
Q2 | $3.98M | Buy |
150,985
+27,296
| +22% | +$720K | 0.03% | 586 |
|
|
2024
Q1 | $3.76M | Buy |
123,689
+22,139
| +22% | +$672K | 0.03% | 656 |
|
|
2023
Q4 | $2.85M | Sell |
101,550
-30,879
| -23% | -$867K | 0.02% | 714 |
|
|
2023
Q3 | $3.59M | Buy |
132,429
+21,220
| +19% | +$576K | 0.03% | 604 |
|
|
2023
Q2 | $3.42M | Buy |
111,209
+355
| +0.3% | +$10.9K | 0.03% | 658 |
|
|
2023
Q1 | $3.99M | Sell |
110,854
-15,761
| -12% | -$568K | 0.03% | 604 |
|
|
2022
Q4 | $5M | Buy |
126,615
+30,977
| +32% | +$1.22M | 0.04% | 526 |
|
|
2022
Q3 | $3.84M | Sell |
95,638
-25,420
| -21% | -$1.02M | 0.04% | 595 |
|
|
2022
Q2 | $5.09M | Sell |
121,058
-9,874
| -8% | -$415K | 0.04% | 531 |
|
|
2022
Q1 | $5.1M | Sell |
130,932
-13,733
| -9% | -$535K | 0.03% | 642 |
|
|
2021
Q4 | $5.77M | Buy |
144,665
+25,476
| +21% | +$1.02M | 0.03% | 630 |
|
|
2021
Q3 | $4.31M | Buy |
119,189
+110,123
| +1,215% | +$3.98M | 0.03% | 721 |
|
|
2021
Q2 | $372K | Buy |
+9,066
| New | +$372K | ﹤0.01% | 1938 |
|